<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01012245</url>
  </required_header>
  <id_info>
    <org_study_id>912-OPT-0091-131</org_study_id>
    <secondary_id>A6111100, 912-OPT-0091-131</secondary_id>
    <nct_id>NCT01012245</nct_id>
  </id_info>
  <brief_title>Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom</brief_title>
  <acronym>XCHANGE</acronym>
  <official_title>Project &quot;XCHANGE&quot; Non-Interventional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-interventional study to obtain real life data from the treatment with Xalatan and Xalacom
      in Germany and to assess the long-term efficacy and tolerability under routine conditions.
      Data were entered into an electronic case report form.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Intraocular Pressure (IOP)</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Aulhorn Stage (Visual Field Defects)</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Optic Disc Excavation: Vertical Cup to Disc Ratio</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Optic Disc Excavation: Horizontal Cup to Disc Ratio</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator Assessment of Xalatan® Efficacy</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Assessment of Satisfaction With Xalatan® Treatment</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity (Visus)</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Impairment Due to Glaucoma</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Self-care: Application of Eye Drops</measure>
    <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for Changes in Glaucoma Therapy</measure>
    <time_frame>January 2000 through December 2008</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator Assessment of Tolerability of Xalatan® Treatment</measure>
    <time_frame>Baseline up to 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for Discontinuation From Study</measure>
    <time_frame>January 2000 through December 2008</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes to the Color of the Iris During Xalatan® or Xalacom® Treatment</measure>
    <time_frame>Baseline up to 3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">28812</enrollment>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>patients with glaucoma and ocular hypertension</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <arm_group_label>patients with glaucoma and ocular hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with glaucoma or ocular hypertension treated by office-based ophthalmologists
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with ocular hypertension or glaucoma, defined by SmPC

        Exclusion Criteria:

          -  defined by SmPC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=912-OPT-0091-131&amp;StudyName=Non-Interventional%20Study%20In%20Patients%20With%20Ocular%20Hypertension%20And%20Open%20Angle%20Glaucoma%20Treated%20With%20Xalatan%20And%20Xalacom</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2009</study_first_submitted>
  <study_first_submitted_qc>November 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <results_first_submitted>December 11, 2009</results_first_submitted>
  <results_first_submitted_qc>December 11, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 21, 2010</results_first_posted>
  <last_update_submitted>February 18, 2010</last_update_submitted>
  <last_update_submitted_qc>February 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2010</last_update_posted>
  <responsible_party>
    <name_title>Director, Clinical Trial Disclosure Group</name_title>
    <organization>Pfizer, Inc.</organization>
  </responsible_party>
  <keyword>Xchange</keyword>
  <keyword>Xalatan</keyword>
  <keyword>Xalacom</keyword>
  <keyword>Betablocker</keyword>
  <keyword>observational</keyword>
  <keyword>longterm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Latanoprost</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Open-label, prospective, multi-center, non-interventional cohort study (NIS) at 385 centers (office-based ophthalmologists); number of subjects per center was not limited.</recruitment_details>
      <pre_assignment_details>Subjects were assigned to a therapeutic strategy within current practice and not according to a protocol.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Subjects With Glaucoma and Ocular Hypertension</title>
          <description>All subjects group: documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups: Xalatan®: subjects with Xalatan® (latanoprost) monotherapy at baseline visit; Betablockers: subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit; Xalacom®: subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit; other medications: subjects with other or no hypotensive therapy at baseline visit.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28812"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26385">More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2427"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Xalatan®</title>
          <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
        </group>
        <group group_id="B2">
          <title>Betablockers</title>
          <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit</description>
        </group>
        <group group_id="B3">
          <title>Xalacom®</title>
          <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
        </group>
        <group group_id="B4">
          <title>Other Medication</title>
          <description>Subjects with other or no hypotensive therapy at baseline visit</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13486"/>
            <count group_id="B2" value="1884"/>
            <count group_id="B3" value="746"/>
            <count group_id="B4" value="12696"/>
            <count group_id="B5" value="28812"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.9" spread="13.4"/>
                    <measurement group_id="B2" value="65.3" spread="12.7"/>
                    <measurement group_id="B3" value="66.5" spread="12.7"/>
                    <measurement group_id="B4" value="66.9" spread="13.3"/>
                    <measurement group_id="B5" value="65.9" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7636"/>
                    <measurement group_id="B2" value="1101"/>
                    <measurement group_id="B3" value="383"/>
                    <measurement group_id="B4" value="7493"/>
                    <measurement group_id="B5" value="16613"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5850"/>
                    <measurement group_id="B2" value="783"/>
                    <measurement group_id="B3" value="363"/>
                    <measurement group_id="B4" value="5203"/>
                    <measurement group_id="B5" value="12199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Concomitant ocular diseases at baseline</title>
          <description>Number of subjects per type of concomitant ocular diseases present at baseline visit for right eye (OD) and left eye (OS). Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than 1 category.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Concomitant ocular disease (right eye [OD])</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13137"/>
                    <measurement group_id="B2" value="1846"/>
                    <measurement group_id="B3" value="731"/>
                    <measurement group_id="B4" value="12328"/>
                    <measurement group_id="B5" value="28042"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Concomitant ocular disease (left eye [OS])</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13179"/>
                    <measurement group_id="B2" value="1847"/>
                    <measurement group_id="B3" value="732"/>
                    <measurement group_id="B4" value="12350"/>
                    <measurement group_id="B5" value="28108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No concomitant diseases OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6737"/>
                    <measurement group_id="B2" value="1060"/>
                    <measurement group_id="B3" value="315"/>
                    <measurement group_id="B4" value="4742"/>
                    <measurement group_id="B5" value="12854"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No concomitant diseases OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6730"/>
                    <measurement group_id="B2" value="1067"/>
                    <measurement group_id="B3" value="308"/>
                    <measurement group_id="B4" value="4757"/>
                    <measurement group_id="B5" value="12862"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least 1 concomitant disease OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5426"/>
                    <measurement group_id="B2" value="786"/>
                    <measurement group_id="B3" value="416"/>
                    <measurement group_id="B4" value="6488"/>
                    <measurement group_id="B5" value="13116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least 1 concomitant disease OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5460"/>
                    <measurement group_id="B2" value="780"/>
                    <measurement group_id="B3" value="424"/>
                    <measurement group_id="B4" value="6492"/>
                    <measurement group_id="B5" value="13156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post cataract surgery OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="309"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="731"/>
                    <measurement group_id="B5" value="1100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post cataract surgery OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="338"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="752"/>
                    <measurement group_id="B5" value="1149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post glaucoma surgery OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1276"/>
                    <measurement group_id="B2" value="189"/>
                    <measurement group_id="B3" value="109"/>
                    <measurement group_id="B4" value="1799"/>
                    <measurement group_id="B5" value="3373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post glaucoma surgery OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1292"/>
                    <measurement group_id="B2" value="184"/>
                    <measurement group_id="B3" value="107"/>
                    <measurement group_id="B4" value="1729"/>
                    <measurement group_id="B5" value="3312"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post laser surgery for glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="656"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="1070"/>
                    <measurement group_id="B5" value="1836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Status post laser surgery for glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="637"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="64"/>
                    <measurement group_id="B4" value="1061"/>
                    <measurement group_id="B5" value="1818"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cataract OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2297"/>
                    <measurement group_id="B2" value="370"/>
                    <measurement group_id="B3" value="209"/>
                    <measurement group_id="B4" value="2542"/>
                    <measurement group_id="B5" value="5418"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cataract OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2302"/>
                    <measurement group_id="B2" value="370"/>
                    <measurement group_id="B3" value="220"/>
                    <measurement group_id="B4" value="2587"/>
                    <measurement group_id="B5" value="5479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other disease OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2249"/>
                    <measurement group_id="B2" value="280"/>
                    <measurement group_id="B3" value="147"/>
                    <measurement group_id="B4" value="2639"/>
                    <measurement group_id="B5" value="5315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other disease OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2269"/>
                    <measurement group_id="B2" value="285"/>
                    <measurement group_id="B3" value="143"/>
                    <measurement group_id="B4" value="2633"/>
                    <measurement group_id="B5" value="5330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="974"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1098"/>
                    <measurement group_id="B5" value="2072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="989"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1101"/>
                    <measurement group_id="B5" value="2090"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Concomitant systemic diseases at baseline</title>
          <description>Number of subjects per type of concomitant systemic disease present at baseline visit. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No concomitant diseases</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6895"/>
                    <measurement group_id="B2" value="1045"/>
                    <measurement group_id="B3" value="396"/>
                    <measurement group_id="B4" value="5734"/>
                    <measurement group_id="B5" value="14070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least 1 concomitant disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5638"/>
                    <measurement group_id="B2" value="839"/>
                    <measurement group_id="B3" value="350"/>
                    <measurement group_id="B4" value="5854"/>
                    <measurement group_id="B5" value="12681"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1644"/>
                    <measurement group_id="B2" value="247"/>
                    <measurement group_id="B3" value="107"/>
                    <measurement group_id="B4" value="1743"/>
                    <measurement group_id="B5" value="3741"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asthma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="532"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="484"/>
                    <measurement group_id="B5" value="1063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiac insufficiency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="891"/>
                    <measurement group_id="B2" value="136"/>
                    <measurement group_id="B3" value="48"/>
                    <measurement group_id="B4" value="1118"/>
                    <measurement group_id="B5" value="2193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypotension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="347"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="288"/>
                    <measurement group_id="B5" value="734"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2257"/>
                    <measurement group_id="B2" value="453"/>
                    <measurement group_id="B3" value="192"/>
                    <measurement group_id="B4" value="2288"/>
                    <measurement group_id="B5" value="5190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1696"/>
                    <measurement group_id="B2" value="200"/>
                    <measurement group_id="B3" value="75"/>
                    <measurement group_id="B4" value="1902"/>
                    <measurement group_id="B5" value="3873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="953"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1108"/>
                    <measurement group_id="B5" value="2061"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glaucoma diagnosis at baseline</title>
          <description>Number of subjects per each type of glaucoma diagnosis present at baseline visit for OD and OS. Column numbers may not equal the total number of participants analyzed as subjects could meet criteria for more than one category.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Glaucoma chronicum simplex OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9863"/>
                    <measurement group_id="B2" value="1595"/>
                    <measurement group_id="B3" value="560"/>
                    <measurement group_id="B4" value="9266"/>
                    <measurement group_id="B5" value="21284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glaucoma chronicum simplex OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9874"/>
                    <measurement group_id="B2" value="1590"/>
                    <measurement group_id="B3" value="562"/>
                    <measurement group_id="B4" value="9269"/>
                    <measurement group_id="B5" value="21295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal tension glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="818"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="55"/>
                    <measurement group_id="B4" value="486"/>
                    <measurement group_id="B5" value="1410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal tension glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="834"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="507"/>
                    <measurement group_id="B5" value="1447"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronic narrow-angle glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="496"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="804"/>
                    <measurement group_id="B5" value="1365"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chronic narrow-angle glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="503"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="804"/>
                    <measurement group_id="B5" value="1372"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Congenital glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="58"/>
                    <measurement group_id="B5" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Congenital glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="55"/>
                    <measurement group_id="B5" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Exfoliation glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="339"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="381"/>
                    <measurement group_id="B5" value="776"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Exfoliation glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="335"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="390"/>
                    <measurement group_id="B5" value="777"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pigment dispersion glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="155"/>
                    <measurement group_id="B5" value="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pigment dispersion glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="150"/>
                    <measurement group_id="B5" value="309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neovascular glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="93"/>
                    <measurement group_id="B5" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neovascular glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="73"/>
                    <measurement group_id="B5" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other secondary glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="242"/>
                    <measurement group_id="B5" value="426"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other secondary glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="262"/>
                    <measurement group_id="B5" value="446"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acute angle closure OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acute angle closure OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ocular hypertension OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="987"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="467"/>
                    <measurement group_id="B5" value="1559"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ocular hypertension OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="987"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="468"/>
                    <measurement group_id="B5" value="1564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="283"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="365"/>
                    <measurement group_id="B5" value="667"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="287"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="363"/>
                    <measurement group_id="B5" value="673"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No glaucoma OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="262"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="267"/>
                    <measurement group_id="B5" value="581"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No glaucoma OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="230"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="259"/>
                    <measurement group_id="B5" value="539"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values OD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="101"/>
                    <measurement group_id="B5" value="189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values OS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="87"/>
                    <measurement group_id="B5" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of glaucoma disease at baseline</title>
          <description>Duration in years for glaucoma disease present at baseline visit.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.1" spread="5.6"/>
                    <measurement group_id="B2" value="6.0" spread="5.9"/>
                    <measurement group_id="B3" value="6.6" spread="6.1"/>
                    <measurement group_id="B4" value="6.6" spread="6.8"/>
                    <measurement group_id="B5" value="5.9" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Intraocular Pressure (IOP)</title>
        <description>Mean IOP values measured by applanation tonometry. Only Goldman values are displayed; if values were given for both right and left eye, the value of the right eye was analyzed. Change (absolute difference) calculated as mean of (value of IOP at observation minus baseline value). Study course is reported by yearly intervals and clustered as 1 year (12±3 months), 2 years (24±3 months), and 3 years (36±3 months).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group and each treatment group population. N=number of participants with IOP data at baseline; (n)=number of participants with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups.</description>
          </group>
          <group group_id="O2">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O3">
            <title>Betablockers</title>
            <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit.</description>
          </group>
          <group group_id="O4">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
          <group group_id="O5">
            <title>Other Medications</title>
            <description>Subjects with other or no hypotensive therapy at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Intraocular Pressure (IOP)</title>
          <description>Mean IOP values measured by applanation tonometry. Only Goldman values are displayed; if values were given for both right and left eye, the value of the right eye was analyzed. Change (absolute difference) calculated as mean of (value of IOP at observation minus baseline value). Study course is reported by yearly intervals and clustered as 1 year (12±3 months), 2 years (24±3 months), and 3 years (36±3 months).</description>
          <population>All subjects group and each treatment group population. N=number of participants with IOP data at baseline; (n)=number of participants with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20073"/>
                <count group_id="O2" value="8735"/>
                <count group_id="O3" value="1508"/>
                <count group_id="O4" value="494"/>
                <count group_id="O5" value="9336"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 year (n=10886,4134, 357, 209, 3029)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="4.4"/>
                    <measurement group_id="O2" value="-0.7" spread="3.5"/>
                    <measurement group_id="O3" value="-1.0" spread="3.4"/>
                    <measurement group_id="O4" value="-0.2" spread="3.5"/>
                    <measurement group_id="O5" value="-1.1" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years (n=7558, 2631, 175, 80, 1834)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="4.5"/>
                    <measurement group_id="O2" value="-0.7" spread="3.6"/>
                    <measurement group_id="O3" value="-0.8" spread="3.2"/>
                    <measurement group_id="O4" value="-0.5" spread="3.1"/>
                    <measurement group_id="O5" value="-1.4" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years (n=5023, 1753, 64, 40, 1115)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="4.5"/>
                    <measurement group_id="O2" value="-0.7" spread="3.7"/>
                    <measurement group_id="O3" value="-1.2" spread="3.1"/>
                    <measurement group_id="O4" value="-0.3" spread="3.2"/>
                    <measurement group_id="O5" value="-1.4" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>IOP 1 year (n=11602)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.2</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>17.2</ci_lower_limit>
            <ci_upper_limit>17.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>IOP 1 year (n=4450)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.8</ci_lower_limit>
            <ci_upper_limit>17.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>IOP 1 year (n=357)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.3</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.2</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>17.1</ci_lower_limit>
            <ci_upper_limit>17.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>IOP 1 year (n=220)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.2</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.4</ci_lower_limit>
            <ci_upper_limit>17.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>IOP 1 year (n=3277)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.6</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.1</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>17.5</ci_lower_limit>
            <ci_upper_limit>17.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>IOP 2 years (n=8051)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>17.0</ci_lower_limit>
            <ci_upper_limit>17.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>IOP 2 years (n=2808)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.9</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.7</ci_lower_limit>
            <ci_upper_limit>16.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>IOP 2 years (n=175)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.2</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>17.0</ci_lower_limit>
            <ci_upper_limit>17.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>IOP 2 years (n=83)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.6</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>15.9</ci_lower_limit>
            <ci_upper_limit>17.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>IOP 2 years (n=2002)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.1</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.7</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.9</ci_lower_limit>
            <ci_upper_limit>17.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>IOP 3 years (n=5469)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.4</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.9</ci_lower_limit>
            <ci_upper_limit>17.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>IOP 3 years (n=1932)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.8</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.2</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.7</ci_lower_limit>
            <ci_upper_limit>17.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>IOP 3 years (n=64)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>17.5</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.9</ci_lower_limit>
            <ci_upper_limit>18.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>IOP 3 years (n=44)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.5</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.8</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>15.7</ci_lower_limit>
            <ci_upper_limit>17.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>IOP 3 years (n=1251)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>16.9</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>16.7</ci_lower_limit>
            <ci_upper_limit>17.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Aulhorn Stage (Visual Field Defects)</title>
        <description>Number of subjects at each Aulhorn stage. Staged as: No scotoma; Stage I (relative scotomas only), Stage II (absolute scotomas without connection to the blind spot), Stage III (absolute scotomas with connection to the blind spot), Stage IV (absolute scotomas more than 1 quadrant affected), and Stage V (temporal residual visual field only). If values were given for both right and left eye, the value of the right eye was analyzed.</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group and all treatment groups populations</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups.</description>
          </group>
          <group group_id="O2">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O3">
            <title>Betablockers</title>
            <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit.</description>
          </group>
          <group group_id="O4">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
          <group group_id="O5">
            <title>Other Medications</title>
            <description>Subjects with other or no hypotensive therapy at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Aulhorn Stage (Visual Field Defects)</title>
          <description>Number of subjects at each Aulhorn stage. Staged as: No scotoma; Stage I (relative scotomas only), Stage II (absolute scotomas without connection to the blind spot), Stage III (absolute scotomas with connection to the blind spot), Stage IV (absolute scotomas more than 1 quadrant affected), and Stage V (temporal residual visual field only). If values were given for both right and left eye, the value of the right eye was analyzed.</description>
          <population>All subjects group and all treatment groups populations</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28812"/>
                <count group_id="O2" value="13486"/>
                <count group_id="O3" value="1884"/>
                <count group_id="O4" value="746"/>
                <count group_id="O5" value="12696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: No scotoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7753"/>
                    <measurement group_id="O2" value="4074"/>
                    <measurement group_id="O3" value="493"/>
                    <measurement group_id="O4" value="200"/>
                    <measurement group_id="O5" value="2986"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Stage I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3759"/>
                    <measurement group_id="O2" value="1915"/>
                    <measurement group_id="O3" value="254"/>
                    <measurement group_id="O4" value="68"/>
                    <measurement group_id="O5" value="1522"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Stage II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1904"/>
                    <measurement group_id="O2" value="826"/>
                    <measurement group_id="O3" value="119"/>
                    <measurement group_id="O4" value="47"/>
                    <measurement group_id="O5" value="912"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1313"/>
                    <measurement group_id="O2" value="467"/>
                    <measurement group_id="O3" value="51"/>
                    <measurement group_id="O4" value="57"/>
                    <measurement group_id="O5" value="738"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Stage IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="949"/>
                    <measurement group_id="O2" value="268"/>
                    <measurement group_id="O3" value="29"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="635"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Stage V</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="646"/>
                    <measurement group_id="O2" value="210"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="415"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12488"/>
                    <measurement group_id="O2" value="5726"/>
                    <measurement group_id="O3" value="925"/>
                    <measurement group_id="O4" value="349"/>
                    <measurement group_id="O5" value="5488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: No scotoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4493"/>
                    <measurement group_id="O2" value="2068"/>
                    <measurement group_id="O3" value="157"/>
                    <measurement group_id="O4" value="94"/>
                    <measurement group_id="O5" value="903"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Stage I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1763"/>
                    <measurement group_id="O2" value="840"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="423"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Stage II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="868"/>
                    <measurement group_id="O2" value="326"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="576"/>
                    <measurement group_id="O2" value="180"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="259"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Stage IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="372"/>
                    <measurement group_id="O2" value="83"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Stage V</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8820"/>
                    <measurement group_id="O2" value="3438"/>
                    <measurement group_id="O3" value="171"/>
                    <measurement group_id="O4" value="168"/>
                    <measurement group_id="O5" value="2342"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: No scotoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3374"/>
                    <measurement group_id="O2" value="1491"/>
                    <measurement group_id="O3" value="121"/>
                    <measurement group_id="O4" value="43"/>
                    <measurement group_id="O5" value="572"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Stage I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1339"/>
                    <measurement group_id="O2" value="583"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Stage II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="603"/>
                    <measurement group_id="O2" value="193"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="396"/>
                    <measurement group_id="O2" value="120"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Stage IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="241"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Stage V</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6107"/>
                    <measurement group_id="O2" value="2181"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="76"/>
                    <measurement group_id="O5" value="1471"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: No scotoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2323"/>
                    <measurement group_id="O2" value="1017"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="347"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Stage I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="933"/>
                    <measurement group_id="O2" value="416"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Stage II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420"/>
                    <measurement group_id="O2" value="132"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="288"/>
                    <measurement group_id="O2" value="82"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Stage IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Stage V</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4283"/>
                    <measurement group_id="O2" value="1515"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="924"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Optic Disc Excavation: Vertical Cup to Disc Ratio</title>
        <description>Mean vertical cup to disc (cup/disc or C/D) ratio to assess the progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). If values were given for both right and left eye, the value of the right eye was analyzed. Change calculated as mean of (value of cup/disc ratio at observation minus baseline value).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group and all treatment groups populations. N=number of participants with optic disc excavation data at baseline; (n)=number of participants with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups.</description>
          </group>
          <group group_id="O2">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O3">
            <title>Betablockers</title>
            <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit.</description>
          </group>
          <group group_id="O4">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
          <group group_id="O5">
            <title>Other Medications</title>
            <description>Subjects with other or no hypotensive therapy at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Optic Disc Excavation: Vertical Cup to Disc Ratio</title>
          <description>Mean vertical cup to disc (cup/disc or C/D) ratio to assess the progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). If values were given for both right and left eye, the value of the right eye was analyzed. Change calculated as mean of (value of cup/disc ratio at observation minus baseline value).</description>
          <population>All subjects group and all treatment groups populations. N=number of participants with optic disc excavation data at baseline; (n)=number of participants with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20375"/>
                <count group_id="O2" value="9521"/>
                <count group_id="O3" value="1276"/>
                <count group_id="O4" value="497"/>
                <count group_id="O5" value="9081"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 year (n=11190, 4638, 72, 236, 2714)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.07"/>
                    <measurement group_id="O2" value="0.00" spread="0.07"/>
                    <measurement group_id="O3" value="0.02" spread="0.08"/>
                    <measurement group_id="O4" value="0.01" spread="0.07"/>
                    <measurement group_id="O5" value="0.00" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years (n=8088, 3128, 26, 93, 1756)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.08"/>
                    <measurement group_id="O2" value="0.01" spread="0.08"/>
                    <measurement group_id="O3" value="0.00" spread="0.09"/>
                    <measurement group_id="O4" value="0.02" spread="0.07"/>
                    <measurement group_id="O5" value="0.01" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years (n=5784, 2173, 16, 34, 1170)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.09"/>
                    <measurement group_id="O2" value="0.01" spread="0.08"/>
                    <measurement group_id="O3" value="0.03" spread="0.09"/>
                    <measurement group_id="O4" value="0.02" spread="0.11"/>
                    <measurement group_id="O5" value="0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 1 year (n=11966)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.46</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.46</ci_lower_limit>
            <ci_upper_limit>0.47</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 1 year (n=4944)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.44</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>0.44</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 1 year (n=88)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.39</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.19</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.35</ci_lower_limit>
            <ci_upper_limit>0.43</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 1 year (n=241)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.50</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.47</ci_lower_limit>
            <ci_upper_limit>0.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 1 year (n=2949)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.27</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.50</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 2 years (n=8783)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.46</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.46</ci_lower_limit>
            <ci_upper_limit>0.47</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 2 years (n=3396)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.43</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.23</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>0.44</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 2 years (n=31)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.39</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.16</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.33</ci_lower_limit>
            <ci_upper_limit>0.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 2 years (n=95)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.49</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>0.54</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 2 years (n=1934)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.27</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.50</ci_lower_limit>
            <ci_upper_limit>0.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 3 years (n=6344)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.45</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>0.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 3 years (n=2372)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.42</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.41</ci_lower_limit>
            <ci_upper_limit>0.43</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 3 years (n=25)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.33</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.27</ci_lower_limit>
            <ci_upper_limit>0.39</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 3 years (n=36)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.47</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.18</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.41</ci_lower_limit>
            <ci_upper_limit>0.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Vertical C/D ratio 3 years (n=1283)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.49</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.48</ci_lower_limit>
            <ci_upper_limit>0.51</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Optic Disc Excavation: Horizontal Cup to Disc Ratio</title>
        <description>Mean horizontal cup to disc (cup/disc or C/D) ratio to assess the progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). If values were given for both right and left eye, the value of the right eye was analyzed. Change calculated as mean of (value of cup/disc ratio at observation minus baseline value).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group and all treatment groups populations. N=number of subjects with optic disc excavation data at baseline; (n)=number of subjects with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups.</description>
          </group>
          <group group_id="O2">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O3">
            <title>Betablockers</title>
            <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit.</description>
          </group>
          <group group_id="O4">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
          <group group_id="O5">
            <title>Other Medications</title>
            <description>Subjects with other or no hypotensive therapy at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Optic Disc Excavation: Horizontal Cup to Disc Ratio</title>
          <description>Mean horizontal cup to disc (cup/disc or C/D) ratio to assess the progression of glaucoma; calculated as the ratio of the diameter of the depression (cup) to that of the optical nerve head (disc). If values were given for both right and left eye, the value of the right eye was analyzed. Change calculated as mean of (value of cup/disc ratio at observation minus baseline value).</description>
          <population>All subjects group and all treatment groups populations. N=number of subjects with optic disc excavation data at baseline; (n)=number of subjects with analyzable data at observation for All subjects, Xalatan®, Betablockers, Xalacom®, and Other medications, respectively.</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19316"/>
                <count group_id="O2" value="9203"/>
                <count group_id="O3" value="1226"/>
                <count group_id="O4" value="469"/>
                <count group_id="O5" value="8418"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 year (n=10602, 4496, 71, 227, 2442)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.07"/>
                    <measurement group_id="O2" value="0.00" spread="0.06"/>
                    <measurement group_id="O3" value="0.02" spread="0.08"/>
                    <measurement group_id="O4" value="0.01" spread="0.07"/>
                    <measurement group_id="O5" value="0.00" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years (n=7727, 3003, 26, 88, 1630)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.08"/>
                    <measurement group_id="O2" value="0.00" spread="0.07"/>
                    <measurement group_id="O3" value="0.00" spread="0.10"/>
                    <measurement group_id="O4" value="0.01" spread="0.06"/>
                    <measurement group_id="O5" value="0.01" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years (n=5500, 2089, 16, 33, 1067)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.09"/>
                    <measurement group_id="O2" value="0.01" spread="0.07"/>
                    <measurement group_id="O3" value="0.01" spread="0.08"/>
                    <measurement group_id="O4" value="0.02" spread="0.11"/>
                    <measurement group_id="O5" value="0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 1 year (n=11433)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.45</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>0.46</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 1 year (n=4810)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.42</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.23</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>0.43</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 1 year (n=87)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.37</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.19</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.33</ci_lower_limit>
            <ci_upper_limit>0.42</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 1 year (n=232)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.50</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.47</ci_lower_limit>
            <ci_upper_limit>0.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 1 year (n=2703)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.27</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.50</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 2 years (n=8427)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.45</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>0.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 2 years (n=3276)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.41</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.23</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.40</ci_lower_limit>
            <ci_upper_limit>0.42</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 2 years (n=31)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.38</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.19</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.31</ci_lower_limit>
            <ci_upper_limit>0.45</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 2 years (n=92)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.50</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>0.56</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 2 years (n=1812)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.27</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.49</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 3 years (n=6102)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.43</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>0.44</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 3 years (n=2289)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.40</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.22</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>0.41</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 3 years (n=25)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.31</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.15</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.25</ci_lower_limit>
            <ci_upper_limit>0.38</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 3 years (n=35)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.49</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>0.57</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Horizontal C/D ratio 3 years (n=1204)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean value</param_type>
            <param_value>0.48</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.47</ci_lower_limit>
            <ci_upper_limit>0.50</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Assessment of Xalatan® Efficacy</title>
        <description>Number of subjects for Investigator assessment of the efficacy of Xalatan® treatment rated as excellent (highly effective), very good, good, moderate, sufficient, and insufficient (not effective).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>Xalatan® treatment group only (subjects with Xalatan® monotherapy at baseline visit).</population>
        <group_list>
          <group group_id="O1">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Assessment of Xalatan® Efficacy</title>
          <description>Number of subjects for Investigator assessment of the efficacy of Xalatan® treatment rated as excellent (highly effective), very good, good, moderate, sufficient, and insufficient (not effective).</description>
          <population>Xalatan® treatment group only (subjects with Xalatan® monotherapy at baseline visit).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="555"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11285"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="310"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="475"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1828"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="256"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1307"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Assessment of Satisfaction With Xalatan® Treatment</title>
        <description>Number of subjects for assessment of subject satisfaction with Xalatan® treatment; categorized as excellent (full satisfaction), very good, good, moderate, sufficient, and insufficient (no satisfaction).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>Xalatan® treatment group only (subjects with Xalatan monotherapy at baseline visit).</population>
        <group_list>
          <group group_id="O1">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Assessment of Satisfaction With Xalatan® Treatment</title>
          <description>Number of subjects for assessment of subject satisfaction with Xalatan® treatment; categorized as excellent (full satisfaction), very good, good, moderate, sufficient, and insufficient (no satisfaction).</description>
          <population>Xalatan® treatment group only (subjects with Xalatan monotherapy at baseline visit).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="901"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="737"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="621"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1832"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="343"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1499"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Acuity (Visus)</title>
        <description>Number of subjects with visual acuity evaluations: amaurosis (partial or total loss of sight); hand movements (able to detect gross object and motion perception without detailed discrimination); finger count (able to count fingers at a given distance); visual acuity scale: range 0.05 (low acuity) to &gt;1.2 (greater acuity). If values were given for both the right eye and left eye, the value of the right eye was analyzed.</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group and all treatment groups populations</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension at baseline visit; includes subjects from the 4 treatment groups.</description>
          </group>
          <group group_id="O2">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O3">
            <title>Betablockers</title>
            <description>Subjects with only 1 betablocker and subjects with more than one betablocker at baseline visit.</description>
          </group>
          <group group_id="O4">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
          <group group_id="O5">
            <title>Other Medications</title>
            <description>Subjects with other or no hypotensive therapy at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity (Visus)</title>
          <description>Number of subjects with visual acuity evaluations: amaurosis (partial or total loss of sight); hand movements (able to detect gross object and motion perception without detailed discrimination); finger count (able to count fingers at a given distance); visual acuity scale: range 0.05 (low acuity) to &gt;1.2 (greater acuity). If values were given for both the right eye and left eye, the value of the right eye was analyzed.</description>
          <population>All subjects group and all treatment groups populations</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28812"/>
                <count group_id="O2" value="13486"/>
                <count group_id="O3" value="1884"/>
                <count group_id="O4" value="746"/>
                <count group_id="O5" value="12696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: Amaurosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Hand movements</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="503"/>
                    <measurement group_id="O2" value="176"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Finger count</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="241"/>
                    <measurement group_id="O2" value="94"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.05</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="766"/>
                    <measurement group_id="O2" value="238"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="485"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="553"/>
                    <measurement group_id="O2" value="194"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="759"/>
                    <measurement group_id="O2" value="308"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="399"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="902"/>
                    <measurement group_id="O2" value="355"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="27"/>
                    <measurement group_id="O5" value="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1345"/>
                    <measurement group_id="O2" value="567"/>
                    <measurement group_id="O3" value="62"/>
                    <measurement group_id="O4" value="33"/>
                    <measurement group_id="O5" value="683"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2173"/>
                    <measurement group_id="O2" value="941"/>
                    <measurement group_id="O3" value="138"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="1038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2780"/>
                    <measurement group_id="O2" value="1242"/>
                    <measurement group_id="O3" value="217"/>
                    <measurement group_id="O4" value="84"/>
                    <measurement group_id="O5" value="1237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1799"/>
                    <measurement group_id="O2" value="846"/>
                    <measurement group_id="O3" value="107"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="805"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4984"/>
                    <measurement group_id="O2" value="2329"/>
                    <measurement group_id="O3" value="395"/>
                    <measurement group_id="O4" value="132"/>
                    <measurement group_id="O5" value="2128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 0.9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1880"/>
                    <measurement group_id="O2" value="928"/>
                    <measurement group_id="O3" value="130"/>
                    <measurement group_id="O4" value="50"/>
                    <measurement group_id="O5" value="772"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8685"/>
                    <measurement group_id="O2" value="4505"/>
                    <measurement group_id="O3" value="613"/>
                    <measurement group_id="O4" value="222"/>
                    <measurement group_id="O5" value="3345"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 1.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: 1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="513"/>
                    <measurement group_id="O2" value="258"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: &gt;1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117"/>
                    <measurement group_id="O2" value="77"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="734"/>
                    <measurement group_id="O2" value="382"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Amaurosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Hand movements</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="319"/>
                    <measurement group_id="O2" value="97"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Finger counts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="179"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.05</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="291"/>
                    <measurement group_id="O2" value="86"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="238"/>
                    <measurement group_id="O2" value="74"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="381"/>
                    <measurement group_id="O2" value="127"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="484"/>
                    <measurement group_id="O2" value="160"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="720"/>
                    <measurement group_id="O2" value="270"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1225"/>
                    <measurement group_id="O2" value="463"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1663"/>
                    <measurement group_id="O2" value="625"/>
                    <measurement group_id="O3" value="68"/>
                    <measurement group_id="O4" value="38"/>
                    <measurement group_id="O5" value="494"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1087"/>
                    <measurement group_id="O2" value="418"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="301"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2872"/>
                    <measurement group_id="O2" value="1161"/>
                    <measurement group_id="O3" value="116"/>
                    <measurement group_id="O4" value="57"/>
                    <measurement group_id="O5" value="697"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 0.9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1152"/>
                    <measurement group_id="O2" value="489"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="224"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4687"/>
                    <measurement group_id="O2" value="2242"/>
                    <measurement group_id="O3" value="106"/>
                    <measurement group_id="O4" value="78"/>
                    <measurement group_id="O5" value="844"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 1.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: 1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="322"/>
                    <measurement group_id="O2" value="152"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: &gt;1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1384"/>
                    <measurement group_id="O2" value="521"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="555"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Amaurosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Hand movements</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="214"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Finger counts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.05</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="191"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="188"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="351"/>
                    <measurement group_id="O2" value="111"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="470"/>
                    <measurement group_id="O2" value="150"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="856"/>
                    <measurement group_id="O2" value="309"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1167"/>
                    <measurement group_id="O2" value="385"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="738"/>
                    <measurement group_id="O2" value="255"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2051"/>
                    <measurement group_id="O2" value="775"/>
                    <measurement group_id="O3" value="63"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="424"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 0.9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="900"/>
                    <measurement group_id="O2" value="352"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3437"/>
                    <measurement group_id="O2" value="1607"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="33"/>
                    <measurement group_id="O5" value="536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 1.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: 1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="234"/>
                    <measurement group_id="O2" value="97"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: &gt;1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="955"/>
                    <measurement group_id="O2" value="335"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Amaurosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Hand movements</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Finger counts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.05</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="194"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="227"/>
                    <measurement group_id="O2" value="65"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="342"/>
                    <measurement group_id="O2" value="107"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="606"/>
                    <measurement group_id="O2" value="207"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="789"/>
                    <measurement group_id="O2" value="258"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="534"/>
                    <measurement group_id="O2" value="185"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1369"/>
                    <measurement group_id="O2" value="538"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 0.9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="593"/>
                    <measurement group_id="O2" value="210"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 1.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2487"/>
                    <measurement group_id="O2" value="1147"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="347"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 1.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: 1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                    <measurement group_id="O2" value="61"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: &gt;1.2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="662"/>
                    <measurement group_id="O2" value="243"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Impairment Due to Glaucoma</title>
        <description>Number of subjects per level of visual impairment categorized as not at all (no impairment), a little bit, moderate, severe, and very severe (very severe impairment).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group; not summarized by subgroups</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension and a documented glaucoma medication at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Impairment Due to Glaucoma</title>
          <description>Number of subjects per level of visual impairment categorized as not at all (no impairment), a little bit, moderate, severe, and very severe (very severe impairment).</description>
          <population>All subjects group; not summarized by subgroups</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28812"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: Not at all</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9368"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: A little bit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="627"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Very severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11688"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Not at all</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: A little bit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Very severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4440"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Not at all</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4917"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: A little bit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2961"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="715"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Very severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Not at all</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: A little bit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="501"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Very severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2584"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Self-care: Application of Eye Drops</title>
        <description>Number of subjects per level of ability for application (administration) of eye drops categorized as without the help of nursing staff (apply without help) and with the help of nursing staff (apply with help).</description>
        <time_frame>Baseline, 1 year, 2 years, and 3 years</time_frame>
        <population>All subjects group; not summarized by subgroups</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension and a documented glaucoma medication at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Self-care: Application of Eye Drops</title>
          <description>Number of subjects per level of ability for application (administration) of eye drops categorized as without the help of nursing staff (apply without help) and with the help of nursing staff (apply with help).</description>
          <population>All subjects group; not summarized by subgroups</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28812"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: apply without help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16520"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: apply with help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: apply without help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12415"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: apply with help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="919"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: apply without help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8657"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: apply with help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: apply without help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: apply with help</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reasons for Changes in Glaucoma Therapy</title>
        <description>Number of subjects for each reason for change of therapy; there may be more than one reason possible per patient. Reasons for changes in glaucoma therapy was reported from January 2000 through December 2008 independent of the duration of any individual subject's time on study.</description>
        <time_frame>January 2000 through December 2008</time_frame>
        <population>Subjects from the all subjects group that changed therapy through the duration of the study; subjects who changed from or changed to &quot;other&quot; therapy (Other Medication) were not included in this analysis; not summarized by subgroups.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension and a documented glaucoma medication at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons for Changes in Glaucoma Therapy</title>
          <description>Number of subjects for each reason for change of therapy; there may be more than one reason possible per patient. Reasons for changes in glaucoma therapy was reported from January 2000 through December 2008 independent of the duration of any individual subject's time on study.</description>
          <population>Subjects from the all subjects group that changed therapy through the duration of the study; subjects who changed from or changed to &quot;other&quot; therapy (Other Medication) were not included in this analysis; not summarized by subgroups.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8895"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Wish for better compliance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wish for stronger IOP decrease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3474"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wish for better local tolerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wish for better systemic tolerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No medication until now</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="490"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other reason</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3859"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigator Assessment of Tolerability of Xalatan® Treatment</title>
        <description>Number of subjects for the Investigator's assessment of subjects tolerability of Xalatan® treatment categorized as excellent, very good, good, moderate, sufficient, or insufficient. The occurrence of adverse events (a side effect that may not have any causal relationship to study treatment) was documented as tolerability data.</description>
        <time_frame>Baseline up to 3 years</time_frame>
        <population>Xalatan® treatment group only (subjects with Xalatan monotherapy at baseline visit).</population>
        <group_list>
          <group group_id="O1">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Assessment of Tolerability of Xalatan® Treatment</title>
          <description>Number of subjects for the Investigator's assessment of subjects tolerability of Xalatan® treatment categorized as excellent, very good, good, moderate, sufficient, or insufficient. The occurrence of adverse events (a side effect that may not have any causal relationship to study treatment) was documented as tolerability data.</description>
          <population>Xalatan® treatment group only (subjects with Xalatan monotherapy at baseline visit).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13486"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="619"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1075"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="449"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11285"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="986"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3429"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2437"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1795"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Excellent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Very good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1571"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1281"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years: Missing values</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reasons for Discontinuation From Study</title>
        <description>Number of subjects per reason for discontinuation from the study. More than one reason for discontinuation is possible per patient. Discontinuation analysis was performed independent of the duration of any individual subject's time on study.</description>
        <time_frame>January 2000 through December 2008</time_frame>
        <population>Subjects from the All subjects group population who discontinued the study.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>Documented diagnosis of glaucoma or ocular hypertension and a documented glaucoma medication at baseline visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons for Discontinuation From Study</title>
          <description>Number of subjects per reason for discontinuation from the study. More than one reason for discontinuation is possible per patient. Discontinuation analysis was performed independent of the duration of any individual subject's time on study.</description>
          <population>Subjects from the All subjects group population who discontinued the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2427"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lost to follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="717"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject's death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subject moved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="320"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse event</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="337"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other reason</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="302"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes to the Color of the Iris During Xalatan® or Xalacom® Treatment</title>
        <description>Number of subjects with documented change to the color of the iris during treatment with Xalatan® or Xalacom®.</description>
        <time_frame>Baseline up to 3 years</time_frame>
        <population>Xalatan® treatment group (subjects with Xalatan® (latanoprost) monotherapy at baseline visit) and Xalacom® treatment group (latanoprost + timolol maleate) therapy at baseline visit. During the course of the study the data structure (scaling of color) was changed in a way that change in iris color was no longer evaluable; data not summarized.</population>
        <group_list>
          <group group_id="O1">
            <title>Xalatan®</title>
            <description>Subjects with Xalatan® (latanoprost) monotherapy at baseline visit</description>
          </group>
          <group group_id="O2">
            <title>Xalacom®</title>
            <description>Subjects with Xalacom® (latanoprost + timolol maleate) therapy at baseline visit</description>
          </group>
        </group_list>
        <measure>
          <title>Changes to the Color of the Iris During Xalatan® or Xalacom® Treatment</title>
          <description>Number of subjects with documented change to the color of the iris during treatment with Xalatan® or Xalacom®.</description>
          <population>Xalatan® treatment group (subjects with Xalatan® (latanoprost) monotherapy at baseline visit) and Xalacom® treatment group (latanoprost + timolol maleate) therapy at baseline visit. During the course of the study the data structure (scaling of color) was changed in a way that change in iris color was no longer evaluable; data not summarized.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data for Adverse drug reactions was reported January 2000 through December 2008 through the duration of the study independent of the duration of any individual subject's time on study.</time_frame>
      <desc>Side effects = Adverse drug reactions: determination by the health-care professional of causal relationship between occurrence of side effect and drug being used; includes ocular and systemic side effects. Reported for All subjects group population.</desc>
      <group_list>
        <group group_id="E1">
          <title>All Subjects</title>
          <description>Subjects with documented diagnosis of glaucoma or ocular hypertension at baseline visit.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (12.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6936" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="220" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Anophthalmos</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Developmental glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Distichiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal sensation in eye</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Accommodation disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Acquired corneal dystrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Amblyopia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Anterior capsule contraction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Anterior chamber disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Asthenopia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Astigmatism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Chalazion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctival hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctival irritation</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctival oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctival pigmentation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal decompensation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal epithelium defect</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal erosion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal infiltrates</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal oedema</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal opacity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal pigmentation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal thinning</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cyanopsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dark circles under eyes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Ectropion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eczema eyelids</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Entropion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Erythema of eyelid</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye discharge</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="2252" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eyelash discolouration</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eyelid oedema</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eyelid sensory disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eyelids pruritus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Foreign body sensation in eyes</sub_title>
                <counts group_id="E1" subjects_affected="1150" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Growth of eyelashes</sub_title>
                <counts group_id="E1" subjects_affected="148" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hypermetropia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hyphaema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia eye</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Iris disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Iris hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Iris hypopigmentation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Keratoconjunctivitis sicca</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Maculopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Miosis</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Mydriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Myodesopsia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Myopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Night blindness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="3760" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Optic disc haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Optic nerve cupping</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Posterior capsule opacification</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Presbyopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Punctate keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Pupils unequal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Retinal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Scleral discolouration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Scotoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sicca syndrome</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Trichiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Vitreous opacities</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="197" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Tongue dry</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Drug ineffective</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Drug intolerance</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1510" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Mucosal dryness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal graft rejection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="873" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Multiple allergies</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Reaction to preservatives</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Adenoviral conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Herpes ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Corneal scar</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure decreased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Intraocular pressure decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Intraocular pressure fluctuation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Thyroid function test normal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cerebellar ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cerebrosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="431" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Senile dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affect lability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="204" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Increased upper airway secretion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Nasal dryness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Throat tightness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hair colour changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hair growth abnormal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hypertrichosis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Ingrown hair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Rosacea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Skin hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Yellow skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Treatment noncompliance</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Corneal transplant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye excision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye laser surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Eye prosthesis insertion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Photocoagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Angiosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28812"/>
              </event>
              <event>
                <sub_title>Raynaud's phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28812"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of &lt; 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), &lt; 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Except at baseline, number of subjects analyzed in treatment groups do not necessarily summarize to “All subjects” total; subjects drop out of treatment group when therapy changes. “All subjects” shows all subjects irrespective of any therapy change.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.govCallCenter@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

